Secondary Risk-Reducing Strategies for Contralateral Breast Cancer in BRCA1/2 Variant Carriers: A Systematic Review and Meta-analysis.

Adv Ther · 2025 · PMC12795943 · PMID 39609372

Europe PMC DOI

hedged sentences

—

closest p

—

boldest claim

The sentences

an increasing trendno p-value reported

(2016), who suggested an increasing trend of tamoxifen efficacy in reducing CBC risk among the general patients with breast cancer.

also in 63,971 other papers

a decreasing trendno p-value reported

Our study indicates a decreasing trend of tamoxifen efficacy in reducing CBC risk among BRCA carriers who were ER-positive.

also in 47,180 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.